Express Scripts by Evernorth, a Cigna company, is suing the Federal Trade Commission, demanding that it retract a July report on the pharmacy benefit manager industry.
Category: Pharma, Life Sciences, Care
Large PBMs control 70% of the market, report finds
Newly published data suggests low competition among middling players in the pharmaceutical supply chain, with numbers showing that the four largest pharmacy benefit managers in the country control roughly 70% of the national market.
Evernorth making Stelara biosimilar available for $0 out-of-pocket
Evernorth Health Services, a subsidiary of Cigna, plans to have a Stelara biosimilar available for $0 out-of-pocket cost for eligible patients of its specialty pharmacy, Accredo, beginning in early 2025.
